I am going to come to what we are going to do in the future. The current situation will remain in place for one year, but we have identified the public health spend. A significant proportion of the funding will be allocated to HIV testing and prevention activities. We also recognise that there are reasonable concerns about the practicalities as we move towards business rates retention, and how it will work in practice, in particular in relation to health. The fact is that the only way we are going to get the scale right is if we continue to engage closely with Members. One thing we are looking at is how we manage the move towards mandation and how we look at transparency and accountability in public health spending. We will be doing that in a very consultative way—
HIV Treatment
Proceeding contribution from
Baroness Blackwood of North Oxford
(Conservative)
in the House of Commons on Wednesday, 29 March 2017.
It occurred during Debate on HIV Treatment.
About this proceeding contribution
Reference
624 c168WH Session
2016-17Chamber / Committee
Westminster HallSubjects
Librarians' tools
Timestamp
2022-08-30 09:19:32 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2017-03-29/17032944000118
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2017-03-29/17032944000118
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2017-03-29/17032944000118